Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- Emergent BioSolutions Inc (NYSE: EBS) has been in headlines after its Baltimore plant has drawn the scrutiny of the FDA.
- A manufacturing mix-up ruined 15 million Johnson & Johnson (NYSE: JNJ) COVID-19 vaccine doses at the Baltimore plant.
- Last month, the FDA completed its inspection of the troubled vaccine manufacturing plant and released a couple of blistering observations on the cross-contamination, sanitary issues, and lack of staff training.
- Today, Emergent responded to FDA’s observations with a comprehensive quality enhancement plan.
- Emergent said it has already started making improvements and is committed to making the necessary short and long-term enhancements to meet or exceed FDA’s standards.
- The company is continuing into an ongoing dialogue with the FDA and Johnson & Johnson to resume production.
- Price Action: EBS shares are trading 1.3% higher at $59.55 during the market session on the last check Wednesday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!